Cargando…
A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease
OBJECTIVE: To determine psychometric properties of the PROMIS-10 and Standard Stroke Question Set (by International Consortium for Health Outcome Measures) presented as a new 15-item Patient Related Outcome (PRO), for patients with: acquired Brain Injury (ABI), Multiple sclerosis (MS) and Parkinson’...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177510/ https://www.ncbi.nlm.nih.gov/pubmed/34086698 http://dx.doi.org/10.1371/journal.pone.0251484 |
_version_ | 1783703394806923264 |
---|---|
author | Carter, Ben Hayes, Chloe Smith, Alexander Pennington, Anna Price, Michelle Pearson, Owen Vitoratou, Silia Hewitt, Jonathan |
author_facet | Carter, Ben Hayes, Chloe Smith, Alexander Pennington, Anna Price, Michelle Pearson, Owen Vitoratou, Silia Hewitt, Jonathan |
author_sort | Carter, Ben |
collection | PubMed |
description | OBJECTIVE: To determine psychometric properties of the PROMIS-10 and Standard Stroke Question Set (by International Consortium for Health Outcome Measures) presented as a new 15-item Patient Related Outcome (PRO), for patients with: acquired Brain Injury (ABI), Multiple sclerosis (MS) and Parkinson’s disease (PD). METHODS: In an eight centre, UK wide, cross-sectional study we approached patients during their routine follow-up to complete: a disease-specific instrument (European Brain Injury Questionnaire, Multiple Sclerosis Impact Scale, and Parkinson’s disease questionnaire); General Health questionnaire with a Quality of life measure (EQ-5D); and PRO. We validated the PRO using factor analysis to define the latent construct domains, then calculated the internal consistency (Cronbach’s-α), and construct validity (correlation). RESULTS: There were 340 patients with ABI (N = 91, median age = 55.1, 41% female), MS (N = 99, age = 58.9, 69%) and PD (N = 150, age = 74.5, 40%). Factor analysis suggested the PRO offered three domains of: physical health; functionality-capacity and mental health. All factors correlated strongly with the three disease-specific instruments, and the overall PRO had a large correlation with the EQ-5D (correlation>0.8) offering good construct validity and excellent internal consistency (∝>0.89). INTERPRETATION: The PRO offered promising psychometric properties and could be used in place of disease specific questionnaires for patients with ABI, MS, and PD. The PRO has three construct domains, describing patients’: mental health; physical health; and functional-capacity, and may be used in routine clinical practice. The PRO offered both relevance to each of the three separate neurological conditions and generalisability across all the conditions, increasing its utility. |
format | Online Article Text |
id | pubmed-8177510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-81775102021-06-07 A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease Carter, Ben Hayes, Chloe Smith, Alexander Pennington, Anna Price, Michelle Pearson, Owen Vitoratou, Silia Hewitt, Jonathan PLoS One Research Article OBJECTIVE: To determine psychometric properties of the PROMIS-10 and Standard Stroke Question Set (by International Consortium for Health Outcome Measures) presented as a new 15-item Patient Related Outcome (PRO), for patients with: acquired Brain Injury (ABI), Multiple sclerosis (MS) and Parkinson’s disease (PD). METHODS: In an eight centre, UK wide, cross-sectional study we approached patients during their routine follow-up to complete: a disease-specific instrument (European Brain Injury Questionnaire, Multiple Sclerosis Impact Scale, and Parkinson’s disease questionnaire); General Health questionnaire with a Quality of life measure (EQ-5D); and PRO. We validated the PRO using factor analysis to define the latent construct domains, then calculated the internal consistency (Cronbach’s-α), and construct validity (correlation). RESULTS: There were 340 patients with ABI (N = 91, median age = 55.1, 41% female), MS (N = 99, age = 58.9, 69%) and PD (N = 150, age = 74.5, 40%). Factor analysis suggested the PRO offered three domains of: physical health; functionality-capacity and mental health. All factors correlated strongly with the three disease-specific instruments, and the overall PRO had a large correlation with the EQ-5D (correlation>0.8) offering good construct validity and excellent internal consistency (∝>0.89). INTERPRETATION: The PRO offered promising psychometric properties and could be used in place of disease specific questionnaires for patients with ABI, MS, and PD. The PRO has three construct domains, describing patients’: mental health; physical health; and functional-capacity, and may be used in routine clinical practice. The PRO offered both relevance to each of the three separate neurological conditions and generalisability across all the conditions, increasing its utility. Public Library of Science 2021-06-04 /pmc/articles/PMC8177510/ /pubmed/34086698 http://dx.doi.org/10.1371/journal.pone.0251484 Text en © 2021 Carter et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Carter, Ben Hayes, Chloe Smith, Alexander Pennington, Anna Price, Michelle Pearson, Owen Vitoratou, Silia Hewitt, Jonathan A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease |
title | A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease |
title_full | A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease |
title_fullStr | A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease |
title_full_unstemmed | A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease |
title_short | A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson’s disease |
title_sort | single patient reported outcome measure for acquired brain injury, multiple sclerosis & parkinson’s disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177510/ https://www.ncbi.nlm.nih.gov/pubmed/34086698 http://dx.doi.org/10.1371/journal.pone.0251484 |
work_keys_str_mv | AT carterben asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT hayeschloe asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT smithalexander asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT penningtonanna asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT pricemichelle asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT pearsonowen asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT vitoratousilia asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT hewittjonathan asinglepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT carterben singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT hayeschloe singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT smithalexander singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT penningtonanna singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT pricemichelle singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT pearsonowen singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT vitoratousilia singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease AT hewittjonathan singlepatientreportedoutcomemeasureforacquiredbraininjurymultiplesclerosisparkinsonsdisease |